October Pharma S.A.E (EGX:OCPH)

Egypt · Delayed Price · Currency is EGP

210.61

-1.47 (-0.69%)

At close: Nov 12, 2026

Market Cap	5.05B +109.0%
Revenue (ttm)	1.46B +22.5%
Net Income	165.09M +11.7%
EPS	6.88 +4.4%
Shares Out	24.00M
PE Ratio	30.62
Forward PE	n/a
Dividend	1.25 (0.59%)
Ex-Dividend Date	n/a

Volume	27,476
Open	212.08
Previous Close	212.08
Day's Range	180.00 - 220.00
52-Week Range	82.50 - 341.99
Beta	0.79
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 19, 2026

About October Pharma S.A.E

October Pharma S.A.E manufactures and sells pharmaceutical products in Egypt. The company provides human medicines in the form of capsules, tablets, suppositories, syrup, and drops for internal and sprays and inhalers for external use. October Pharma S.A.E was incorporated in 1987 is based in Cairo, Egypt. [Read more]

Industry Pharmaceutical Preparations

Founded 1987

Country Egypt

Stock Exchange Egyptian Stock Exchange

Ticker Symbol OCPH

Full Company Profile

Financial Performance

In 2024, October Pharma S.A.E's revenue was 1.23 billion, an increase of 21.39% compared to the previous year's 1.01 billion. Earnings were 131.26 million, a decrease of -12.72%.

Financial Statements